109 related articles for article (PubMed ID: 11905524)
41. Long-term effects of liver transplantation on bone mineral density in children with end-stage liver disease: a 2-year prospective study.
Okajima H; Shigeno C; Inomata Y; Egawa H; Uemoto S; Asonuma K; Kiuchi T; Konishi J; Tanaka K
Liver Transpl; 2003 Apr; 9(4):360-4. PubMed ID: 12682886
[TBL] [Abstract][Full Text] [Related]
42. Long-term persistence of low bone density in orthotopic liver transplantation.
Giannini S; Nobile M; Ciuffreda M; Iemmolo RM; Dalle Carbonare L; Minicuci N; Casagrande F; Destro C; Gerunda GE; Sartori L; Crepaldi G
Osteoporos Int; 2000; 11(5):417-24. PubMed ID: 10912844
[TBL] [Abstract][Full Text] [Related]
43. Bone mineral density after kidney transplantation. A cross-sectional study in 190 graft recipients up to 20 years after transplantation.
Grotz WH; Mundinger FA; Gugel B; Exner VM; Kirste G; Schollmeyer PJ
Transplantation; 1995 Apr; 59(7):982-6. PubMed ID: 7709459
[TBL] [Abstract][Full Text] [Related]
44. Effects of three immunosuppressive regimens on vertebral bone density in renal transplant recipients: a prospective study.
Aroldi A; Tarantino A; Montagnino G; Cesana B; Cocucci C; Ponticelli C
Transplantation; 1997 Feb; 63(3):380-6. PubMed ID: 9039927
[TBL] [Abstract][Full Text] [Related]
45. Effects of Epidural Steroid Injections on Bone Mineral Density and Bone Turnover Markers in Patients Taking Anti-Osteoporotic Medications.
Nah SY; Lee JH; Lee JH
Pain Physician; 2018 Jul; 21(4):E435-E447. PubMed ID: 30045610
[TBL] [Abstract][Full Text] [Related]
46. Better late than never? Experience with intravenous pamidronate treatment in patients with low bone mass or fractures following cardiac or liver transplantation.
Dodidou P; Bruckner T; Hosch S; Haass M; Klar E; Sauer P; Ziegler R; Leidig-Bruckner G
Osteoporos Int; 2003 Jan; 14(1):82-9. PubMed ID: 12577189
[TBL] [Abstract][Full Text] [Related]
47. Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis.
Struys A; Snelder AA; Mulder H
Am J Med; 1995 Sep; 99(3):235-42. PubMed ID: 7653482
[TBL] [Abstract][Full Text] [Related]
48. Ibandronate in stable renal transplant recipients with low bone mineral density on long-term follow-up.
Tillmann FP; Schmitz M; Jäger M; Krauspe R; Rump LC
Int Urol Nephrol; 2016 Feb; 48(2):279-86. PubMed ID: 26498632
[TBL] [Abstract][Full Text] [Related]
49. Alternate-day prednisone in the maintenance immunosuppressive therapy after orthotopic liver transplantation.
Pedrosa MC; Rohrer RM; Kaplan MM
Clin Transplant; 1995 Aug; 9(4):322-5. PubMed ID: 7579741
[TBL] [Abstract][Full Text] [Related]
50. Long-term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid-sensitive nephrotic syndrome.
Leonard MB; Feldman HI; Shults J; Zemel BS; Foster BJ; Stallings VA
N Engl J Med; 2004 Aug; 351(9):868-75. PubMed ID: 15329424
[TBL] [Abstract][Full Text] [Related]
51. Change in bone mineral density at one year following glucocorticoid withdrawal in kidney transplant recipients.
Ing SW; Sinnott LT; Donepudi S; Davies EA; Pelletier RP; Lane NE
Clin Transplant; 2011; 25(2):E113-23. PubMed ID: 20961333
[TBL] [Abstract][Full Text] [Related]
52. Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation.
Monegal A; Navasa M; Guañabens N; Peris P; Pons F; Martinez de Osaba MJ; Rimola A; Rodés J; Muñoz-Gómez J
Calcif Tissue Int; 1997 Feb; 60(2):148-54. PubMed ID: 9056162
[TBL] [Abstract][Full Text] [Related]
53. Lumbar bone mineral density in renal transplant patients on neoral and tacrolimus: a four-year prospective study.
Marcén R; Caballero C; Pascual J; Teruel JL; Tenorio M; Ocaña J; Villafruela JJ; Burgos FJ; Fernández AM; Muriel A; Ortuño J
Transplantation; 2006 Mar; 81(6):826-31. PubMed ID: 16570003
[TBL] [Abstract][Full Text] [Related]
54. Changes in bone mass early after kidney transplantation.
Horber FF; Casez JP; Steiger U; Czerniak A; Montandon A; Jaeger P
J Bone Miner Res; 1994 Jan; 9(1):1-9. PubMed ID: 8154303
[TBL] [Abstract][Full Text] [Related]
55. Short-term increases in bone turnover markers predict parathyroid hormone-induced spinal bone mineral density gains in postmenopausal women with glucocorticoid-induced osteoporosis.
Lane NE; Sanchez S; Genant HK; Jenkins DK; Arnaud CD
Osteoporos Int; 2000; 11(5):434-42. PubMed ID: 10912846
[TBL] [Abstract][Full Text] [Related]
56. Bone mineral density before and after OLT: long-term follow-up and predictive factors.
Guichelaar MM; Kendall R; Malinchoc M; Hay JE
Liver Transpl; 2006 Sep; 12(9):1390-402. PubMed ID: 16933236
[TBL] [Abstract][Full Text] [Related]
57. [Dual-energy X-ray absorptiometry of the vertebrae: determining which vertebrae should be scanned].
Rubinacci A; De Ponti A; Moro GL; Sirtori P; Galli L
Radiol Med; 1992 Dec; 84(6):725-30. PubMed ID: 1494672
[TBL] [Abstract][Full Text] [Related]
58. A prospective cohort analysis of adjacent vertebral body bone mineral density in lumbar surgery patients with or without instrumented posterolateral fusion: a 9- to 12-year follow-up.
Singh K; An HS; Samartzis D; Nassr A; Provus J; Hickey M; Andersson GB
Spine (Phila Pa 1976); 2005 Aug; 30(15):1750-5. PubMed ID: 16094277
[TBL] [Abstract][Full Text] [Related]
59. Bone Mineral Density of Very Long-term Survivors After Childhood Liver Transplantation.
Ee LC; Noble C; Fawcett J; Cleghorn GJ
J Pediatr Gastroenterol Nutr; 2018 May; 66(5):797-801. PubMed ID: 29287007
[TBL] [Abstract][Full Text] [Related]
60. Changes in bone mineral density following discontinuation or continuation of alendronate therapy in glucocorticoid-treated patients: a retrospective, observational study.
Emkey R; Delmas PD; Goemaere S; Liberman UA; Poubelle PE; Daifotis AG; Verbruggen N; Lombardi A; Czachur M
Arthritis Rheum; 2003 Apr; 48(4):1102-8. PubMed ID: 12687554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
